Bank Of Montreal »

Design Therapeutics shares owned by Bank Of Montreal

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Bank Of Montreal from 13F filings

Historical chart of Bank Of Montreal investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Bank Of Montreal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Bank Of Montreal

Quarter filed Position value Share count Share price at filing
2023-06-30 $630k 99k 6.35

More positions owned by Bank Of Montreal

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bk Nova Cad (BNS)
Netflix (NFLX)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)

View all positions for Bank Of Montreal

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Point72 Asset Management
BlackRock
Frazier Life Sciences Management
Tang Capital Management
Baker Bros. Advisors
Vanguard Group
Almitas Capital
Driehaus Capital Management
Kynam Capital Management
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management

View all funds holding Design Therapeutics